From: Aetiology of acute febrile illness among children attending a tertiary hospital in southern Ethiopia
Name of antimicrobial | E. coli n (%) (N = 38) | Klebsiella spp. n (%) (N = 20) | Other Gram-negative n (%) (N = 15) | S. aureus n (%) (N = 21) | Other Gram-positive (n/N) | All isolates n (%)¶ | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Susceptible | Resistant | Susceptible | Resistant | Susceptible | Resistant | Susceptible | Resistant | Susceptible | Resistant | Susceptible | Resistant | |
Ampicillin | 0 (0) | 37 (97.4) | 1 (5.3)b | 18 (90.0)b | 4 (28.6)d | 10 (71.4)d | – | – | (1/4) | (3/4) | 6 (8.0)m | 68 (90.7)m |
Trimethoprim-sulfamethoxazole | 3 (7.9) | 35 (92.1) | 3 (15.0) | 17 (85.0) | 4 (26.7) | 11 (73.3) | 7 (33.3) | 14 (66.7) | (0/1) | (1/1) | 17 (17.9)p | 78 (82.1)p |
Tetracycline | 6 (15.8) | 30 (78.9) | 5 (25.0) | 14 (70.0) | 5 (35.7)d | 7 (50.0)d | 3 (15.0)k | 16 (80.0)k | (0/4) | (4/4) | 19 (19.8)q | 71 (74.0)q |
Amoxicillin and clavulanic acid | 8 (21.1) | 26 (68.4) | 4 (20.0) | 10 (50.0) | 6 (42.9)d | 7 (50.0)d | – | – | – | – | 18 (25.0)r | 43 (59.7)r |
Ceftriaxone | 14 (36.8) | 20 (52.6) | 7 (35.0) | 13 (65.0) | 7 (53.8)e | 4 (30.8)e | – | – | (0/1) | (1/1) | 28 (38.9)r | 38 (52.8)r |
Ceftazidime | 15 (39.5) | 21 (55.3) | 5 (25.0) | 13 (65.0) | 9 (60.0) | 5 (33.3) | – | – | – | – | 29 (39.7)t | 39 (53.4)t |
Gentamicin | 23 (60.5) | 14 (36.8) | 8 (40.0) | 12 (60.0) | 7 (63.6)f | 4 (36.4)f | 15 (71.4) | 5 (23.8) | (4/5) | (1/5) | 57 (60.0)p | 36 (37.9)p |
Chloramphenicol | 23 (60.5) | 15 (39.5) | 9 (45.0) | 11 (55.0) | 9 (64.3)d | 2 (14.3)d | 18 (85.7) | 3 (14.3) | (2/2) | 0 | 61 (64.2)p | 31 (32.6)p |
Ciprofloxacin | 26 (68.4) | 8 (21.1) | 15 (75.0) | 1 (5.0) | 13 (86.7) | 1 (6.7) | 16 (76.2) | 4 (19.0) | (3/4) | 0 | 73 (74.5)u | 14 (14.3)u |
Meropenem | 33 (86.8) | 2 (5.3) | 16 (80.0) | 1 (5.0) | 7 (46.7) | 2 (13.3) | – | – | – | – | 56 (76.7)t | 5 (6.8)t |
Nitrofurantoin* | 37 (100)a | 0 (0) | 15 (93.8)c | 0 (0) | 7 (87.5)g | 1 (12.5)g | 5 (100)h | 0 (0) | (4/4) | 0 | 68 (97.1)w | 1 (1.4)w |
Norfloxacin* | 27 (73.0)a | 9 (24.3)a | 14 (87.5)c | 1 (5.0)c | 10 (90.9)f | 1 (9.1)f | 4 (80.0)h | 1 (20.0)h | (3/4) | (1/4) | 58 (79.5)t | 13 (17.8)t |
Penicillin G | – |  | – |  | – |  | 3 (15.0)k | 17 (85.0)k | (2/5) | (3/5) | 5 (20.0)x | 20 (80.0)x |
Erythromycin | – |  | – |  | – |  | 10 (47.6) | 11 (52.4) | (1/2) | (1/2) | 11 (47.8)y | 12 (52.2)y |
Cefoxitin | – |  | – |  | – |  | 13 (61.9) | 7 (33.3) | (1/1) | 0 | 14 (63.6)z | 7 (31.8)z |
Clindamycin | – |  | – |  | – |  | 17 (81.9) | 4 (19.0) | (1/2) | (1/2) | 18 (78.3)y | 5 (21.7)y |